← Open Payments lookup

BRYAN ISHMAEL: Open Payments

NPI 1730924085 · KERRVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$898 in 49 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $50 · 2025 $898

Food & beverage: $898
CompanyPaymentsAmount
Janssen Biotech, Inc.13$210
ABBVIE INC.12$197
Madrigal Pharmaceuticals5$97
PFIZER INC.4$80
Ipsen Biopharmaceuticals, Inc3$72
Gilead Sciences, Inc.2$42
GENZYME CORPORATION2$42
Aimmune Therapeutics, Inc.2$39
Ardelyx, Inc.2$34
Celltrion USA Inc.1$25

Products named: TREMFYA, MAVYRET, REZDIFFRA, IQIRVO, XELJANZ, RINVOQ, DUPIXENT, ZENPEP.

Industry payments across TX — which companies pay providers there.